India NTRK Fusion Gene Positive Advanced Solid Tumor Market (2025-2031) | Trends, Growth, Analysis, Companies, Outlook, Competitive Landscape, Industry, Forecast, Value, Segmentation, Size & Revenue, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, 2021 & 2031F

3.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Industry Life Cycle

3.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market - Porter's Five Forces

3.5 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of NTRK fusion gene-positive advanced solid tumors in India

4.2.2 Growing awareness among healthcare professionals about targeted therapies for NTRK fusion gene-positive tumors

4.2.3 Advancements in precision medicine and personalized treatment options for patients with NTRK fusion gene-positive tumors

4.3 Market Restraints

4.3.1 Limited accessibility and affordability of targeted therapies for NTRK fusion gene-positive tumors in India

4.3.2 Challenges in accurate diagnosis and identification of NTRK fusion gene-positive tumors

4.3.3 Regulatory hurdles and delays in the approval of new targeted therapies in the Indian market

6.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Type

6.1.1 Overview and Analysis

6.1.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Therapeutics, 2021- 2031F

6.1.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Diagnostics, 2021- 2031F

6.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market, By End-User

6.2.1 Overview and Analysis

6.2.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F

6.2.3 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Cancer Centers, 2021- 2031F

6.2.4 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Others, 2021- 2031F

7.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Export to Major Countries

7.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Imports from Major Countries

8.1 Number of healthcare facilities offering genetic testing for NTRK fusion gene-positive tumors

8.2 Adoption rate of targeted therapies among patients with NTRK fusion gene-positive tumors

8.3 Rate of successful treatment outcomes and patient responses to targeted therapies

8.4 Investment in research and development of new targeted therapies for NTRK fusion gene-positive tumors

8.5 Number of clinical trials evaluating the efficacy of targeted therapies for NTRK fusion gene-positive tumors

9.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenue Share, By Companies, 2024

10.2 India NTRK Fusion Gene Positive Advanced Solid Tumor Market Competitive Benchmarking, By Operating and Technical Parameters